Anti-CD40 antibody was upregulated in steroid-resistant FSGS, implying that anti-CD40 antibody and anti-UCHL1 antibody might be the biomarkers for differential diagnosis and treatment [109]. The gene discussed is CD40; the disease is focal segmental glomerulosclerosis.